Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul:163:114758.
doi: 10.1016/j.biopha.2023.114758. Epub 2023 May 2.

Therapeutic potential and limitations of curcumin as antimetastatic agent

Affiliations
Free article
Review

Therapeutic potential and limitations of curcumin as antimetastatic agent

Petr Dytrych et al. Biomed Pharmacother. 2023 Jul.
Free article

Abstract

Treatment of metastatic cancer is one of the biggest challenges in anticancer therapy. Curcumin is interesting nature polyphenolic compound with unique biological and medicinal effects, including repression of metastases. High impact studies imply that curcumin can modulate the immune system, independently target various metastatic signalling pathways, and repress migration and invasiveness of cancer cells. This review discusses the potential of curcumin as an antimetastatic agent and describes potential mechanisms of its antimetastatic activity. In addition, possible strategies (curcumin formulation, optimization of the method of administration and modification of its structure motif) to overcome its limitation such as low solubility and bioactivity are also presented. These strategies are discussed in the context of clinical trials and relevant biological studies.

Keywords: Curcumin; Metastasis; Migrastatic agents; Nanoparticles; Tumour targeting.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Petr Dytrych did not have any conflict of interest. Zdeněk Kejík did not have any conflict of interest. Jan Hajduch did not have any conflict of interest. Robert Kaplánek did not have any conflict of interest. Kateřina Veselá did not have any conflict of interest. Kateřina Kučnirová did not have any conflict of interest. Markéta Skaličková did not have any conflict of interest. Anna Venhauerová did not have any conflict of interest. David Hoskovec did not have any conflict of interest. Pavel Martásek did not have any conflict of interest. Milan Jakubek did not have any conflict of interest.

MeSH terms

LinkOut - more resources